187218-03-7 Usage
General Description
(R)-2-Tetrahydroisoquinoline acetic acid hydrochloride is a chemical compound with the formula C11H14NO2Cl. It is a derivative of tetrahydroisoquinoline, a heterocyclic compound containing a 6-membered ring with one nitrogen atom. (R)-2-TETRAHYDROISOQUINOLINE ACETIC ACID HYDROCHLORIDE is in the form of a white solid, and it is commonly used as a pharmaceutical intermediate in the synthesis of various drugs. It has also been studied for its potential neuroprotective and anti-inflammatory properties, making it a promising candidate for the development of new therapeutic agents. Additionally, (R)-2-Tetrahydroisoquinoline acetic acid hydrochloride has potential applications in the treatment of neurological and psychiatric disorders due to its ability to modulate neurotransmitter systems in the brain.
Check Digit Verification of cas no
The CAS Registry Mumber 187218-03-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,7,2,1 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 187218-03:
(8*1)+(7*8)+(6*7)+(5*2)+(4*1)+(3*8)+(2*0)+(1*3)=147
147 % 10 = 7
So 187218-03-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H13NO2.ClH/c13-11(14)6-10-5-8-3-1-2-4-9(8)7-12-10;/h1-4,10,12H,5-7H2,(H,13,14);1H/t10-;/m1./s1
187218-03-7Relevant articles and documents
1-BENZYLSPIRO[PIPERIDINE-4,1′-PYRIDO[3,4-b]indole] ‘co-potentiators’ for minimal function CFTR mutants
Son, Jung-Ho,Phuan, Puay-Wah,Zhu, Jie S.,Lipman, Elena,Cheung, Amy,Tsui, Ka Yi,Tantillo, Dean J.,Verkman, Alan S.,Haggie, Peter M.,Kurth, Mark J.
, (2020/10/26)
We previously identified a spiro [piperidine-4,1-pyrido [3,4-b]indole] class of co-potentiators that function in synergy with existing CFTR potentiators such as VX-770 or GLGP1837 to restore channel activity of a defined subset of minimal function cystic fibrosis transmembrane conductance regulator (CFTR) mutants. Here, structure-activity studies were conducted to improve their potency over the previously identified compound, 20 (originally termed CP-A01). Targeted synthesis of 37 spiro [piperidine-4,1-pyrido [3,4-b]indoles] was generally accomplished using versatile two or three step reaction protocols with each step having high efficiency. Structure-activity relationship studies established that analog 2i, with 6′-methoxyindole and 2,4,5-trifluorobenzyl substituents, had the greatest potency for activation of N1303K-CFTR, with EC50 ~600 nM representing an ~17-fold improvement over the original compound identified in a small molecule screen.